Advanced Filters
noise

breast-cancer Clinical Trials

A listing of breast-cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 2,256 clinical trials
N Nerea Becerra Tomás, PhD

Avocado Consumption and Cellular Aging in Breast Cancer Survivors

Women with breast cancer are at increased risk of comorbidities and premature mortality, potentially due to accelerated biological aging. Telomere attrition has been proposed as a biomarker of this process, which could be mitigated through interventions targeting behavioral factors such as diet. In recent years, avocado has drawn attention in …

40 - 65 years of age Female Phase N/A
N Neil Carleton

Active Surveillance in Older Women With ER+ Breast Cancer

ACTIVE is a prospective, single-arm, phase I/IIa study examining an active surveillance strategy for small, screen-detected, luminal breast cancer. Patients aged 70 or older with clinical stage I ER+/HER2- breast cancer are eligible. The goal of this clinical trial is to learn if an active surveillance strategy (serial imaging rather …

70 years of age Female Phase N/A

Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)

CUPCAKE is a randomized, non-comparative, multicenter, proof-of-concept phase II trial, using the Trials within Cohorts concept(1) to assess the clinical utility of ctDNA monitoring combined with 68Ga-FAPI-46-PET-CT imaging upon ctDNA detection for the surveillance of patients with a non-metastatic TNBC at high risk of relapse. The study has two steps. …

18 years of age Female Phase N/A
K Katherine H. Tkaczuk

Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors

Obesity can pose significant challenges to maintaining long-term health in cancer survivors by increasing their risk of cancer coming back. Eating a healthy diet is an important way to help manage weight and improve overall health. Broccoli microgreens (BMG) are young broccoli plants packed with nutrients, and research suggests they …

years of age Female Phase N/A
A Aurélie Thuleau

Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer

This is a phase II study, preceded by a safety run-in, with two independent cohorts (cohort A in early Triple Negative Breast Cancer (TNBC) patients and cohort B in late in metastatic TNBC patients) designed to evaluate the efficacy of atezolizumab, tiragolumab and chemotherapy.

18 years of age Female Phase 2
T Tatiana Kudryashova

Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer

This study involves two non-randomized groups of patients: the observation group and the comparison group. The comparison group will retrospectively include data on 29 patients with oligometastatic HER2-positive breast cancer who received treatment with trastuzumab-emtansine and had a history of SRT. The prospective part of this study aims to include …

18 years of age Female Phase N/A
J Janine Grohar

LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)

To investigate whether the addition of Fibralign's BioBridge® Collagen Matrix (BioBridge) devices to the standard surgery for vascularized lymph node transfer will improve the outcome of surgical treatment in lymphedema of the upper arm.

18 - 75 years of age All Phase N/A
D Daniela Gold, MD PhD

Laser vs Hyaluronic Acid for GSM in Breast Cancer

All women from the outpatient department with a history of BC and GSM (genitourinary symptoms of menopause) symptoms will be invited to participate. After informed consent patients are either randomized to intravaginal laser or hyaluronic acid suppository treatment intravaginally, respectively. Laser treatment will be performed twice, at baseline and after …

18 - 80 years of age Female Phase N/A
M Mina Sedrak

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

This phase IIa trial studies the side effects of abemaciclib monotherapy in treating patients age 70 years and older with hormone receptor positive, HER2 negative breast cancer that has spread to other places in the body.

70 years of age All Phase 2
T Timiya Nolan, PhD

A QoL Intervention for Young African American Breast Cancer Survivors

The purpose of this two-arm pilot RCT is to evaluate processes and preliminary outcomes of a targeted QOL intervention vs. an attention control among young AA survivors post-treatment for early (I-II) & late (III) stage breast cancer.

18 - 44 years of age Female Phase N/A

Simplify language using AI